Mirae Asset Global Investments’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.64K | Buy |
1,790
+257
| +17% | +$953 | ﹤0.01% | 1529 |
|
|
2025
Q1 | $5.57K | Sell |
1,533
-7
| -0.5% | -$25 | ﹤0.01% | 1509 |
|
|
2024
Q4 | $8.55K | Sell |
1,540
-340
| -18% | -$1.89K | ﹤0.01% | 1531 |
|
|
2024
Q3 | $20.4K | Buy |
1,880
+336
| +22% | +$3.64K | ﹤0.01% | 1431 |
|
|
2024
Q2 | $32.3K | Sell |
1,544
-18,554
| -92% | -$388K | ﹤0.01% | 1320 |
|
|
2024
Q1 | $430K | Sell |
20,098
-1,514
| -7% | -$32.4K | ﹤0.01% | 1969 |
|
|
2023
Q4 | $438K | Buy |
21,612
+2,700
| +14% | +$54.7K | ﹤0.01% | 2027 |
|
|
2023
Q3 | $241K | Sell |
18,912
-1,378
| -7% | -$17.5K | ﹤0.01% | 2229 |
|
|
2023
Q2 | $365K | Buy |
20,290
+466
| +2% | +$8.38K | ﹤0.01% | 2093 |
|
|
2023
Q1 | $341K | Buy |
19,824
+5,084
| +34% | +$87.4K | ﹤0.01% | 2104 |
|
|
2022
Q4 | $327K | Buy |
14,740
+2,189
| +17% | +$48.6K | ﹤0.01% | 2106 |
|
|
2022
Q3 | $100K | Buy |
+12,551
| New | +$100K | ﹤0.01% | 2505 |
|
|
2021
Q1 | – | Sell |
-12,000
| Closed | -$498K | – | 1552 |
|
|
2020
Q4 | $498K | Buy |
+12,000
| New | +$498K | ﹤0.01% | 1317 |
|